Read an expert-led article on the latest advancements in TROP2-targeted antibody-drug conjugates for treating triple-negative breast cancer and improving patient outcomes.
ONCOLOGY Vol 39, Issue 8
New therapies for hepatobiliary cancers show promise, expanding treatment options for patients with advanced disease and challenging conditions.
Explore the latest advancements in c-Met-targeted therapies for NSCLC, including optimal testing strategies and management of adverse events.
Enhancing patient adherence to follow-up care for leukoplakia through habit cessation counseling and patient information leaflets may reduce oral cancer risks.
A patient case of a 76-year-old man with a rare glioblastoma variant showcased the importance of molecular profiling in diagnosing and guiding treatment for brain tumors.
Explore the vital role of palliative care in oncology, addressing misconceptions and enhancing patient support for better end-of-life experiences.
Balancing a career as a pediatric oncologist with leadership responsibilities, Maria C. Velez, MD, shares insights into her passion for the field and ASPHO’s impactful work.
Advertisement
Advertisement
Trending on CancerNetwork
1
KRd Appears to Exhibit Greater Outcomes in Standard-Risk Multiple Myeloma
2
KRd-Based Quadruplets May “Eliminate” Transplant Need for Multiple Myeloma
3
Creating a “Watershed Moment” for Novel Therapeutic Access in Lymphoma
4
FDA Grants FTD to WTX-124 in Advanced Pretreated Cutaneous Melanoma
5
